People come to us for cognitive support for very different reasons. Some are high performers looking to sharpen an already capable mind. Others are dealing with a fog that won’t lift, a memory that isn’t what it was, or a brain that still doesn’t feel right months after a concussion. Most are simply noticing that the mental sharpness they used to take for granted has quietly slipped.

What they share often isn’t a diagnosis. It’s a question: is there a way to give my brain more of what it needs to perform at its best?

At Meeting Point Health, we work with a targeted group of compounds called peptides that address cognitive decline at the biological level. Instead of masking symptoms, these compounds support the brain’s natural capacity to repair, connect, and sustain itself. In this article, we’ll walk through three powerful peptides: Semax, Dihexa, and Cerebrolysin, as well as methylene blue, a compound in a category of its own. You’ll learn exactly how each one works, what patients typically notice, and how they form a comprehensive protocol to support your brain from multiple angles.

1. Semax

Semax is a synthetic peptide derived from adrenocorticotropic hormone (ACTH), a hormone your body already produces. It has been modified specifically to enhance neuroprotective and cognitive effects without the hormonal side effects of the parent molecule. It is administered intranasally, which allows it to bypass the blood-brain barrier and act directly on central nervous system tissue.

Its primary mechanism is the upregulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) – two of the most important proteins governing neuronal survival, plasticity, and the formation of new neural connections. Research has demonstrated significant increases in neurotrophic factor expression in brain tissue following Semax administration, which translates clinically into improved memory consolidation, faster cognitive processing, and an enhanced capacity for learning.

The distinction worth understanding is that Semax isn’t a stimulant. It doesn’t borrow from tomorrow’s energy to make today feel sharper. It prompts your brain to produce more of the signaling proteins it uses to grow, adapt, and repair itself.

What patients typically notice after taking Semax:

  • Improved working memory and recall
  • Greater mental clarity and sustained focus
  • Reduced cognitive fatigue, particularly under demanding conditions
  • Mood stabilization as BDNF plays a significant role in resilience and emotional regulation

2. Dihexa

If Semax works by turning up the brain’s neurotrophic signaling, Dihexa works at a more structural level; it promotes the formation of new synaptic connections, the physical links between neurons that underlie memory, learning, and cognitive function.

Dihexa is a small peptide derived from angiotensin IV, and it works by activating the hepatocyte growth factor (HGF) pathway and its receptor c-Met, a mechanism that plays a critical role in the process of building new synapses. Research has shown it to be extraordinarily potent in this regard, inducing synaptogenesis in hippocampal neurons at concentrations that make it one of the most powerful pro-cognitive compounds studied to date. The hippocampus is the brain’s primary center for memory formation, which is why this pathway is particularly relevant for patients experiencing memory loss or cognitive decline.

In simpler terms: where most cognitive support works at the chemical level by adjusting neurotransmitter availability, Dihexa works at the architectural level, helping the brain physically build more of the infrastructure it uses to think. Clinically, we have observed meaningful improvements in patients that align with what the research suggests,  particularly in areas of memory and fluid reasoning.

What patients typically notice after taking Dihexa:

  • Meaningful improvements in memory retention and recall
  • Enhanced problem-solving and fluid thinking
  • Greater capacity for learning new information
  • Cognitive improvements that tend to feel structural rather than transient

3. Cerebrolysin

Cerebrolysin occupies a different niche than the first two. Where Semax and Dihexa are primarily about optimization and growth, Cerebrolysin is fundamentally about protection and repair. 

It is a peptide mixture derived from porcine brain tissue, containing a carefully standardized profile of low-molecular-weight neuropeptides and amino acids that closely mimic the brain’s own neurotrophic factors. Research has demonstrated its neurotrophic factor-like activity:

  • Supporting neuronal survival
  • Reducing neuroinflammation
  • Enhancing the brain’s ability to repair damaged neurons
  • Restoring degraded neural pathways

It has a particularly well-documented history in the treatment of neurological injury and neurodegenerative conditions, where the priority isn’t just performance but preservation. Cerebrolysin is especially well-suited for post-concussion syndrome, post-viral cognitive impairment, traumatic brain injury recovery, and early neurodegenerative changes –  conditions where the brain has experienced significant stress or damage and needs meaningful support to recover. This is given intravenously, which allows the peptide to reach the CNS without degradation through the digestive tract.

What patients typically notice after taking Cerebrolysin:

  • Gradual but durable improvements in cognitive clarity
  • Better word retrieval and verbal fluency
  • Reduced neurological fatigue
  • Improved mood and emotional resilience in patients with neuroinflammatory burden
4. Methylene Blue

Methylene blue isn’t a peptide. It’s one of the oldest synthetic pharmaceutical compounds in existence, and it has nothing to do with neurotrophic signaling or synaptogenesis. What it does is something more fundamental: it keeps the lights on.

Inside every neuron, mitochondria are constantly converting nutrients into ATP, which is the energy currency the brain runs on. That process depends on the electron transport chain, and specifically on the smooth handoff of electrons through Complexes I through IV. When that chain is inefficient or disrupted, (as it often is in aging, chronic illness, or inflammatory states) neurons don’t produce enough energy to function optimally, regardless of how much neurotrophic support they’re receiving.

Methylene blue acts as an alternative electron carrier, stepping into the electron transport chain and facilitating transfers that might otherwise stall. The result is more efficient ATP production, reduced oxidative stress in mitochondrial tissue, and a meaningfully better-powered brain. Research has linked it to improvements in memory, processing speed, and attention. 

This makes methylene blue a distinct addition to a cognitive protocol – one that works at the energy level while the peptides work at the signaling and structural level. Together, they address cognition from multiple angles simultaneously. Methylene blue is administered orally or intravenously depending on the protocol and clinical goals. IV delivery produces a more immediate and pronounced effect; oral is well-suited for ongoing maintenance.

What patients typically notice after taking methylene blue:

  • Sharper focus and faster mental processing
  • Improved memory consolidation
  • More sustained mental energy without the crash associated with stimulants
  • Enhanced mood as mitochondrial efficiency has downstream effects on neurotransmitter synthesis

Building a Protocol That Makes Sense for You

These four compounds work through different mechanisms, which means they’re not competing with each other; they’re complementary. The right combination depends on what’s actually driving your cognitive symptoms: neurotrophic deficiency, poor synaptic density, neuroinflammation, mitochondrial inefficiency, or some combination of all of the above.

At Meeting Point Health, we evaluate the full picture of your history, labs, specific pattern of symptoms, and build a protocol targeted to benefit your needs.

If cognitive decline, persistent brain fog, post-concussion recovery, or simply not feeling mentally like yourself is something you’re ready to address, schedule a discovery call with Meeting Point Health. 

Related Reading


Peptides for Anxiety and Depression – Semax, Selank, Oxytocin

The Role of Methylene Blue in Treating Chronic Illness

Methylene Blue for Post-Concussive Syndrome – IV with UBI

Frequently Asked Questions

Are these compounds safe? These are emerging compounds and, like many in the field of peptide therapy, long-term human clinical trials are still limited. What we have is a growing body of preclinical research, early human studies, and real-world clinical observation. At Meeting Point Health, these compounds are thoughtfully prescribed with a thorough evaluation of each patient’s history and health status before making any recommendations.

Do I need to use all four, or can I start with one? Protocols are built around what your specific situation calls for. Some patients start with a single compound and expand or stack from there; others benefit from a more comprehensive approach from the outset. There is no universal starting point.

How long does it take to notice results? This varies depending on the compound, the delivery method, and what’s driving your symptoms. Some patients notice changes within days; others see gradual improvement over several weeks. Cerebrolysin in particular tends to produce improvements that build over time rather than appearing immediately.

Do you need a prescription for these peptides and methylene blue? Yes. All of the compounds we use at Meeting Point Health are prescribed and administered under clinical supervision. Clinical oversight is imperative with these compounds. Dosing, delivery method, and protocol design all require a trained eye. We strongly caution against purchasing peptides from online “research” sites, as these products are unregulated, unverified, and not intended for human use.

References

Rojas, J. C., Bruchey, A. K., & Gonzalez-Lima, F. (2012). Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Progress in neurobiology, 96(1), 32–45. https://doi.org/10.1016/j.pneurobio.2011.10.007

Sun, X., Deng, Y., Fu, X., Wang, S., Duan, R., & Zhang, Y. (2021). AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway. Brain sciences, 11(11), 1487. https://doi.org/10.3390/brainsci11111487

Tsai S. J. (2007). Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome. Medical hypotheses, 68(5), 1144–1146. https://doi.org/10.1016/j.mehy.2006.07.017 

Zhang, Y., Chopp, M., Meng, Y., Zhang, Z. G., Doppler, E., Winter, S., Schallert, T., Mahmood, A., & Xiong, Y. (2015). Cerebrolysin improves cognitive performance in rats after mild traumatic brain injury. Journal of neurosurgery, 122(4), 843–855. https://doi.org/10.3171/2014.11.JNS14271 

Written by Amanda Bates, RN and medically reviewed by Dr. Stephen Matta.